Activation of Leukemia Viruses by Graft-Versus-Host and Mixed Lymphocyte Reactions In Vitro
AUTOR(ES)
Hirsch, M. S.
RESUMO
Spleen cells from BALB/c or CAF1 mice released little or no detectable leukemia virus when cultured 2-7 days in vitro. In contrast, spleen cells of CAF1 mice previously inoculated with parental BALB/c spleen cells released leukemia viruses in 10 of 11 cases studied. Cultures of a mixture of spleen cells from normal BALB/c and CAF1 mice also contained leukemia viruses. Phytohemagglutinin induced the transformation of lymphocytes in cultures of CAF1 or BALB/c spleen cells, but this transformation did not activate leukemia viruses. It is concluded that mixed lymphocyte cultures in vitro, just as graft-versus-host reactions in vivo, can activate leukemia viruses that are normally present in a repressed form. This activation is not solely a function of lymphocyte transformation. The activated mouse leukemia virus may subsequently account for the observed high incidence of neoplasia in graft-versus-host disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=426630Documentos Relacionados
- Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat.
- Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation
- Progress in chronic graft-versus-host disease
- Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
- Enhancement of Tumor Growth by Graft-versus-host Reaction